- Home
- BRN vs SNSE Comparison
BRN vs SNSE Comparison
Compare BRN & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- SNSE
- Stock Information
- Founded
- BRN 1956
- SNSE 2005
- Country
- BRN United States
- SNSE United States
- Employees
- BRN N/A
- SNSE 15
- Industry
- BRN Oil & Gas Production
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- SNSE Health Care
- Exchange
- BRN Nasdaq
- SNSE Nasdaq
- Market Cap
- BRN 11.4M
- SNSE 11.2M
- IPO Year
- BRN N/A
- SNSE 2021
- Fundamental
- Price
- BRN $1.16
- SNSE $8.83
- Analyst Decision
- BRN
- SNSE Strong Buy
- Analyst Count
- BRN 0
- SNSE 4
- Target Price
- BRN N/A
- SNSE $72.50
- AVG Volume (30 Days)
- BRN 29.6K
- SNSE 6.5K
- Earning Date
- BRN 08-13-2025
- SNSE 11-13-2025
- Dividend Yield
- BRN N/A
- SNSE N/A
- EPS Growth
- BRN N/A
- SNSE N/A
- EPS
- BRN N/A
- SNSE N/A
- Revenue
- BRN $18,073,000.00
- SNSE N/A
- Revenue This Year
- BRN N/A
- SNSE N/A
- Revenue Next Year
- BRN N/A
- SNSE N/A
- P/E Ratio
- BRN N/A
- SNSE N/A
- Revenue Growth
- BRN N/A
- SNSE N/A
- 52 Week Low
- BRN $1.08
- SNSE $5.00
- 52 Week High
- BRN $2.40
- SNSE $17.40
- Technical
- Relative Strength Index (RSI)
- BRN 51.10
- SNSE 54.78
- Support Level
- BRN $1.08
- SNSE $8.41
- Resistance Level
- BRN $1.19
- SNSE $9.49
- Average True Range (ATR)
- BRN 0.05
- SNSE 0.54
- MACD
- BRN 0.00
- SNSE 0.05
- Stochastic Oscillator
- BRN 62.50
- SNSE 60.68
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).